These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

324 related items for PubMed ID: 12183722

  • 1. Indicators of adult height outcome in classical 21-hydroxylase deficiency congenital adrenal hyperplasia.
    Muirhead S, Sellers EA, Guyda H, Canadian Pediatric Endocrine Group.
    J Pediatr; 2002 Aug; 141(2):247-52. PubMed ID: 12183722
    [Abstract] [Full Text] [Related]

  • 2. Growth inhibition by glucocorticoid treatment in salt wasting 21-hydroxylase deficiency: in early infancy and (pre)puberty.
    Stikkelbroeck NM, Van't Hof-Grootenboer BA, Hermus AR, Otten BJ, Van't Hof MA.
    J Clin Endocrinol Metab; 2003 Aug; 88(8):3525-30. PubMed ID: 12915631
    [Abstract] [Full Text] [Related]

  • 3. Growth patterns and final height in congenital adrenal hyperplasia due to classical 21-hydroxylase deficiency. Results of a multicenter study.
    Hargitai G, Sólyom J, Battelino T, Lebl J, Pribilincová Z, Hauspie R, Kovács J, Waldhauser F, Frisch H, MEWPE-CAH Study Group.
    Horm Res; 2001 Aug; 55(4):161-71. PubMed ID: 11598369
    [Abstract] [Full Text] [Related]

  • 4. Glucocorticoid replacement regimens for treating congenital adrenal hyperplasia.
    Ng SM, Stepien KM, Krishan A.
    Cochrane Database Syst Rev; 2020 Mar 19; 3(3):CD012517. PubMed ID: 32190901
    [Abstract] [Full Text] [Related]

  • 5. [Congenital adrenal hyperplasia due to 21-hydroxylase deficiency: final height in 27 patients with the classical form].
    Lemos-Marini SH, Guerra-Júnior G, Morcillo AM, Baptista MT, Silva LO, Maciel-Guerra AT.
    Arq Bras Endocrinol Metabol; 2005 Dec 19; 49(6):902-7. PubMed ID: 16544012
    [Abstract] [Full Text] [Related]

  • 6. Non-classical 21-hydroxylase deficiency in infancy and childhood: the effect of time of initiation of therapy on puberty and final height.
    Weintrob N, Dickerman Z, Sprecher E, Galatzer A, Pertzelan A.
    Eur J Endocrinol; 1997 Feb 19; 136(2):188-95. PubMed ID: 9116914
    [Abstract] [Full Text] [Related]

  • 7. Growth pattern of untreated boys with simple virilizing congenital adrenal hyperplasia indicates relative androgen insensitivity during the first six months of life.
    Bonfig W, Schwarz HP.
    Horm Res Paediatr; 2011 Feb 19; 75(4):264-8. PubMed ID: 21196707
    [Abstract] [Full Text] [Related]

  • 8. Obesity among children and adolescents with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Völkl TM, Simm D, Beier C, Dörr HG.
    Pediatrics; 2006 Jan 19; 117(1):e98-105. PubMed ID: 16396852
    [Abstract] [Full Text] [Related]

  • 9. [Identification of congenital adrenal hyperplasia by measurement of blood-spot 17-hydroxyprogesterone].
    Sólyom J, Eckhardt G, Török D.
    Orv Hetil; 2004 Oct 03; 145(40):2051-6. PubMed ID: 15559532
    [Abstract] [Full Text] [Related]

  • 10. Recent advances in the diagnosis and management of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Forest MG.
    Hum Reprod Update; 2004 Oct 03; 10(6):469-85. PubMed ID: 15514016
    [Abstract] [Full Text] [Related]

  • 11. Longer term outcome in females with congenital adrenal hyperplasia (CAH): the Cardiff experience.
    Premawardhana LD, Hughes IA, Read GF, Scanlon MF.
    Clin Endocrinol (Oxf); 1997 Mar 03; 46(3):327-32. PubMed ID: 9156043
    [Abstract] [Full Text] [Related]

  • 12. Treatment and disease effects on short-term growth and adult height in children and adolescents with 21-hydroxylase deficiency.
    Hauffa BP, Winter A, Stolecke H.
    Klin Padiatr; 1997 Mar 03; 209(2):71-7. PubMed ID: 9113619
    [Abstract] [Full Text] [Related]

  • 13. Reduced final height outcome in congenital adrenal hyperplasia under prednisone treatment: deceleration of growth velocity during puberty.
    Bonfig W, Bechtold S, Schmidt H, Knorr D, Schwarz HP.
    J Clin Endocrinol Metab; 2007 May 03; 92(5):1635-9. PubMed ID: 17299071
    [Abstract] [Full Text] [Related]

  • 14. Growth pattern during the first 36 months of life in congenital adrenal hyperplasia (21-hydroxylase deficiency).
    Gasparini N, Di Maio S, Salerno M, Argenziano A, Franzese A, Tenore A.
    Horm Res; 1997 May 03; 47(1):17-22. PubMed ID: 9010713
    [Abstract] [Full Text] [Related]

  • 15. Near-final height in 82 Chinese patients with congenital adrenal hyperplasia due to classic 21-hydroxylase deficiency: a single-center study from China.
    Juan L, Huamei M, Zhe S, Yanhong L, Hongshan C, Qiuli C, Jun Z, Song G, Minlian D.
    J Pediatr Endocrinol Metab; 2016 Jul 01; 29(7):841-8. PubMed ID: 27054598
    [Abstract] [Full Text] [Related]

  • 16. Adiponectin levels are high in children with classic congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency.
    Völkl TM, Simm D, Körner A, Kiess W, Kratzsch J, Dörr HG.
    Acta Paediatr; 2009 May 01; 98(5):885-91. PubMed ID: 19236311
    [Abstract] [Full Text] [Related]

  • 17. Molecular testing in congenital adrenal hyperplasia due to 21α-hydroxylase deficiency in the era of newborn screening.
    Sarafoglou K, Lorentz CP, Otten N, Oetting WS, Grebe SK.
    Clin Genet; 2012 Jul 01; 82(1):64-70. PubMed ID: 21534945
    [Abstract] [Full Text] [Related]

  • 18. The relation of peripubertal and pubertal growth to final adult height in children with classic congenital adrenal hyperplasia.
    Bomberg EM, Addo OY, Kyllo J, Gonzalez-Bolanos MT, Ltief AM, Pittock S, Himes JH, Miller BS, Sarafoglou K.
    J Pediatr; 2015 Mar 01; 166(3):743-50. PubMed ID: 25557963
    [Abstract] [Full Text] [Related]

  • 19. Long-term follow-up of children with classic congenital adrenal hyperplasia: suggestions for age dependent treatment in childhood and puberty.
    Pijnenburg-Kleizen KJ, Thomas CMG, Otten BJ, Roeleveld N, Claahsen-van der Grinten HL.
    J Pediatr Endocrinol Metab; 2019 Oct 25; 32(10):1055-1063. PubMed ID: 31573958
    [Abstract] [Full Text] [Related]

  • 20. Adult height of subjects with nonclassical 21-hydroxylase deficiency.
    Eyal O, Tenenbaum-Rakover Y, Shalitin S, Israel S, Weintrob N.
    Acta Paediatr; 2013 Apr 25; 102(4):419-23. PubMed ID: 23298233
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.